OCS Oculis Holding AG

Nasdaq oculis.com


$ 21.40 $ -0.10 (-0.47 %)    

Friday, 24-Oct-2025 15:59:44 EDT
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 21.25
$ 21.50
$ 15.00 x 134
$ 22.00 x 33
$ 20.61 - $ 21.84
$ 14.00 - $ 23.08
107,837
na
348.47M
$ 0.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 chardan-capital-maintains-buy-on-oculis-holding-raises-price-target-to-51

Chardan Capital analyst Daniil Gataulin maintains Oculis Holding (NASDAQ:OCS) with a Buy and raises the price target from $3...

 hc-wainwright--co-maintains-buy-on-oculis-holding-raises-price-target-to-36

HC Wainwright & Co. analyst Yi Chen maintains Oculis Holding (NASDAQ:OCS) with a Buy and raises the price target from $3...

 oculis-advances-privosegtor-into-fda-backed-pivotal-trials-aiming-to-deliver-first-neuroprotective-therapy-for-vision-loss

Oculis Holding AG (NASDAQ:OCS) ("Oculis"), a global biopharmaceutical company focused on innovations addressing neuro-o...

 oculis-reports-trial-results-showing-vision-gains-in-patients-with-acute-optic-neuritis

Oculis Holding AG (NASDAQ:OCS) ("Oculis"), a global biopharmaceutical company focused on innovations for ophthalmic and...

 needham-initiates-coverage-on-oculis-holding-with-buy-rating-announces-price-target-of-36

Needham analyst Serge Belanger initiates coverage on Oculis Holding (NASDAQ:OCS) with a Buy rating and announces Price Targe...

 hc-wainwright--co-maintains-buy-on-oculis-holding-raises-price-target-to-33

HC Wainwright & Co. analyst Yi Chen maintains Oculis Holding (NASDAQ:OCS) with a Buy and raises the price target from $3...

 oculis-holding-q2-eps-057-misses-053-estimate-sales-307417k-beat-250000k-estimate

Oculis Holding (NASDAQ:OCS) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.5...

 chardan-capital-maintains-buy-on-oculis-holding-raises-price-target-to-33

Chardan Capital analyst Daniil Gataulin maintains Oculis Holding (NASDAQ:OCS) with a Buy and raises the price target from $2...

 oculis-holding-q1-eps-069-misses-043-estimate

Oculis Holding (NASDAQ:OCS) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.4...

 chardan-capital-maintains-buy-on-oculis-holding-maintains-28-price-target

Chardan Capital analyst Daniil Gataulin maintains Oculis Holding (NASDAQ:OCS) with a Buy and maintains $28 price target.

 hc-wainwright--co-maintains-buy-on-oculis-holding-raises-price-target-to-32

HC Wainwright & Co. analyst Yi Chen maintains Oculis Holding (NASDAQ:OCS) with a Buy and raises the price target from $2...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION